Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785185 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT02785185 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 150 participants.
The verdict
NCT02785185, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.
Interventions
- DRUG IDP-122 Lotion
- DRUG IDP-122 Vehicle Lotion
- DRUG Ultravate Cream
- DRUG IDP-122 Vehicle Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785185
The ClinicalTrials.gov registry entry for NCT02785185 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IDP-122 Lotion is the first listed.
NCT02785185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02785185 about?
NCT02785185 is a clinical study titled "Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis". A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.
What is the current status of trial NCT02785185?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2016-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02785185?
The interventions under investigation include: IDP-122 Lotion (DRUG), IDP-122 Vehicle Lotion (DRUG), Ultravate Cream (DRUG), IDP-122 Vehicle Cream (DRUG).
Who is sponsoring clinical trial NCT02785185?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.